These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11103934)

  • 1. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
    Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
    Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 transdominance but no gain of function in mouse brain tumor model.
    Hegi ME; Klein MA; Rüedi D; Chène P; Hamou MF; Aguzzi A
    Cancer Res; 2000 Jun; 60(11):3019-24. PubMed ID: 10850451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
    Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
    Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
    Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
    Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A2B5 lineages of human astrocytic tumors and their recurrence.
    Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
    Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
    Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
    Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression.
    Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M
    Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation.
    Haapasalo H; Isola J; Sallinen P; Kalimo H; Helin H; Rantala I
    Am J Pathol; 1993 May; 142(5):1347-51. PubMed ID: 7684193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53 gene and its role in human brain tumors.
    Bögler O; Huang HJ; Kleihues P; Cavenee WK
    Glia; 1995 Nov; 15(3):308-27. PubMed ID: 8586466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of type 1 astrocytes with N-ethyl-N-nitrosourea: establishment of an in vitro system and the role of the p53 gene.
    Hiraga S; Arita N; Ohnishi T; Izumoto S; Taki T; Yamamoto H; Higuchi M; Hayakawa T
    Glia; 1995 Jan; 13(1):51-63. PubMed ID: 7751056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression as exemplified by human astrocytic tumors.
    Collins VP
    Semin Cancer Biol; 1999 Aug; 9(4):267-76. PubMed ID: 10448114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
    Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
    de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of mortalin expression in human brain tumors.
    Takano S; Wadhwa R; Yoshii Y; Nose T; Kaul SC; Mitsui Y
    Exp Cell Res; 1997 Nov; 237(1):38-45. PubMed ID: 9417864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro.
    Bögler O; Nagane M; Gillis J; Huang HJ; Cavenee WK
    Cell Growth Differ; 1999 Feb; 10(2):73-86. PubMed ID: 10074901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
    Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
    Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
    Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.
    Junge CE; Lee CJ; Hubbard KB; Zhang Z; Olson JJ; Hepler JR; Brat DJ; Traynelis SF
    Exp Neurol; 2004 Jul; 188(1):94-103. PubMed ID: 15191806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.